Journal/
conference:
JAMA Neurology
Organisation/s:
Albert Einstein College of Medicine, USA
Funder:
Conflict of Interest Disclosures: Dr Lipton
reported receiving personal fees from Teva
Pharmaceuticals, AbbVie, Axon, Axsome, Biohaven,
Clexio, Eli Lilly, Grifols, Karuna, Lundbeck, Manistee,
Pfizer, Satsuma, Scilex, Shiratronics, Tonix,
CoolTech, and Wizermed and owning stock in
Biohaven, Axon, CoolTech, Manistee, and
Wizermed outside the submitted work. Dr Ramirez
Campos reported being an employee of Teva
Pharmaceuticals during the conduct of this study.
Dr Roth-Ben Arie reported being an employee of
Teva Pharmaceuticals. Dr Galic reported being an
employee of Teva Pharmaceuticals during the
conduct of the study. Dr Mitsikostas reported
receiving principal investigator fees from Teva
Pharmaceuticals; personal fees from Amgen,
Novartis, and Lundbeck; and grants from Eli Lilly
and Pfizer outside the submitted work. Dr Tassorelli
reported receiving payment for trials from IRCCS C.
Mondino Foundation during the conduct of the
study; advisory/speaker fees from Teva
Pharmaceuticals, Pfizer, Eli Lilly, Lundbeck, AbbVie,
and Dompé and grants from AbbVie outside the
submitted work. Dr Denysenko reported receiving
travel support and grants from Teva
Pharmaceuticals and speaker fees from IVPN
Network outside the submitted work. Dr Cohen
reported being a (former) full-time employee of Teva Pharmaceuticals during the conduct of the
study and being a (current) full-time employee of
Braeburn outside the submitted work. No other
disclosures were reported.
Sign In
International
